Work that holds up under scrutiny.

Six weeks of exclusivity on a $310M payments business with licences in four countries.

Integrated financial, regulatory and technology diligence run by one team from a single issues log.

A revenue-recognition issue and a licence gap re-priced the deal and became conditions precedent.

An inspection found record-keeping and consent failures at 9 of 22 clinics, with a re-inspection due in 120 days.

A clinic-by-clinic remediation plan, new consent protocols and weekly evidence packs for the regulator.

All clinics passed re-inspection; the warning notice was withdrawn a month early.

First CSRD report due in 14 months, with ESG data spread across 60 spreadsheets and no controls.

Double materiality assessment, a data and controls build, and a costed abatement plan for the board.

Limited assurance passed first time; the plan unlocked a $250M sustainability-linked loan.

A supervisory review found the audit function under-resourced and 180 actions overdue.

We co-sourced the audit plan, rebuilt action tracking and coached the new chief audit executive.

The regulator closed its review; the in-house team now runs the plan without us.

Margins had halved in three years while volumes grew; each depot ran its own way of working.

A network model, three depot consolidations and a standard operating playbook built with site managers.

Savings delivered ahead of plan, with on-time delivery up from 91% to 97%.

Seven business units, flat growth and an activist investor asking public questions.

A unit-by-unit value review, buyer mapping and a board-ready case for focus.

Two units sold for $410M; proceeds reinvested in the subscription platform.